Stephen Freedland, MD
Enriched profileProfessor of Surgery (Division of Urology), Warschaw Robertson Law Families Chair in Prostate Cancer; Director, Center for Integrated Research in Cancer and Lifestyle; Co-Director, Cancer Genetics and Prevention Program; Associate Director for Faculty Development/Education and Training, Samuel Oschin Comprehensive Cancer Institute · Cedars-Sinai Medical Center
Stephen Freedland is Professor of Surgery (Division of Urology), Warschaw Robertson Law Families Chair in Prostate Cancer; Director, Center for Integrated Research in Cancer and Lifestyle; Co-Director, Cancer Genetics and Prevention Program; Associate Director for Faculty Development/Education and Training, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. OpenAlex indexes 1,629 publications with 43,632 citations (h-index 99); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Stephen J. Freedland is Professor of Surgery (Division of Urology), Warschaw Robertson Law Families Chair in Prostate Cancer at Cedars-Sinai Medical Center, Los Angeles, CA (Division of Urology, Department of Surgery). The public record shows 1,629 publications with 43,632 citations (h-index 99), centered on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism. It also documents an investigator role on 6 registered clinical trials, 9 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · Future oncology (London, England)
- Top research focus: Prostate Cancer Treatment and Research
- 6 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 108 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 532.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
8631 W. Third St., Fourth Floor, Suite 430E, Los Angeles, CA 90048
Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
Sponsor: Edwin Posadas, MD
- Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
Sponsor: National Cancer Institute (NCI)
- WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
Sponsor: Stephen Freedland
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
Cedars-Sinai Medical Center
FY2026$942,724R01CA276919 - Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Cedars-Sinai Medical Center
FY2026$681,082R01CA280081 - Impact of exogenous hormones on Prostate Cancer Risk, Detection, and Outcomes in the Nationwide Veterans Affairs Health System
Cedars-Sinai Medical Center
FY2026$646,784R01CA300694
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.
Future oncology (London, England)
Article2026 - Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations.
JCO clinical cancer informatics
Article2026 - Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.
Journal of the National Cancer Institute
Article2026 - Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice.
Future oncology (London, England)
Article2026
Most-cited works
by citation count (OpenAlex)- 01The Molecular Taxonomy of Primary Prostate Cancer3,229 citations2015
- 02
- 03Autonomic Nerve Development Contributes to Prostate Cancer Progression1,252 citations2013
- 04Early Detection of Prostate Cancer: AUA Guideline1,251 citations2013
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/steve-freedland-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/stephen-freedland-692b23176
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
Mentions by others
where others cite or feature them- Other
urologyhealth.org/healthy-living/urology-care-podcast/prostate-cancer-podcasts/making-informed-choices-about-prostate-cancer-series-real-world-data-with-dr-stephen-freedland
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urologyhealth.org ↗ - ResearchGate
researchgate.net/scientific-contributions/Stephen-J-Freedland-38187799
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/better-cancer-free-lifestyle-factors-and-prostate/id1577215681
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of California, Davis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗
- Fellowship in Urological Oncology
Johns Hopkins
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sharecare.com ↗
Editorial & leadership roles
journal and society appointments- Editor Emeritus (formerly Editor-in-Chief through end of 2021)
Prostate Cancer and Prostatic Diseases (Nature journal)
2021 - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchers.cedars-sinai.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.cedars-sinai.edu ↗
Awards & honors
honors on the public record- Elected member
American Society for Clinical Investigation (ASCI), 2021, honorary society for physician-scientists 50 and younger recognizing outstanding record of scholarly achievement in biomedical research
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗ - Prostate Cancer Foundation (PCF) Award Committee member
Surgical Urologic Oncology section
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pcf.org ↗
Secondary affiliations
appointments beyond the home institution- Staff physician / Principal Investigator
Freedland Urology Research Group, Institute for Medical Research (Durham VA Health Care System affiliate), Durham, NC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →freedlandlab.recruitee.com ↗ - Former Associate Professor with tenure
Division of Urology, Department of Surgery and Department of Pathology, Duke University (prior to Cedars-Sinai)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urologyhealth.org ↗
- The Prostate Health Podcast
Episode 80: "The Effect of Diet and Lifestyle on Prostate Cancer" with Stephen Freedland, MD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prostatehealthpodcast.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Jon Kobashigawa, MD
Cedars-Sinai Medical Center